학술논문

Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
Document Type
Article
Author
Abramof, RAlpenidze, DAronoff, SAstamirova, KBarker, BBedel, GBelousova, LBenson, MBeshay, IBiggs, WBlaze, KBogdanski, PBusch, RChaidarun, SChandran, SChang, AChilka, SCleland, AConnery, LCornett, GDelgado, BDesouza, CDonner, TEliasson, KEriksson, JFolkerth, SForshaw, KFrandsen, H AFrolova, EGandy, WGatipon, GGolovach, AGonzalez-Orozco, LGumprecht, JHaddad, EHansen, T KHart, THasan, SHella, BHeller, SHellgren, MHewitt, MHietaniemi, SHitz, MHouser, PHuntley, RJackson, RJakobsen, P EKapoor, AKargina, LKazakova, EKhan, KKlein, EKnoble, HKrasnopeeva (Kabachkova), NKrzeminski, AKunitsyna, MLawhead, JLevin, KLevin, PLewy-Alterbaum, LLindmark, SLindsay, RLuts, ALysenko, TMadsbad, SMaxwell, TMbogua, CMcknight, JMetsärinne, KMilovanova, TMorawski, EMosenzon, ONabriski, DNguyen, HNicol, PNieminen, SNikkola, ANorwood, PO'Donnell, POdugbesan, AParker, JPergaeva, YPeskov, APlevin, SPouzar, JPratley, RReed, JRossing, PSathyapalan, TSergeeva-Kondrachenko, MShaikh, ZShamkhalova, MShehadeh, NShlesinger, YSilver, RSnyder, BSoufer, JStrand, JSulosaari, STirosh, ATraylor, HUhlenius, NVagapova, GYanovskaya, MZarutskaya, LZhdanova, EMosenzon, OfriBlicher, Thalia MarieRosenlund, SigneEriksson, Jan WHeller, SimonHels, Ole HolmPratley, RichardSathyapalan, ThozhukatDesouza, Cyrus
Source
In The Lancet Diabetes & Endocrinology July 2019 7(7):515-527
Subject
Primary Research
Articles
Language
ISSN
2213-8587